These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1768158)

  • 1. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid.
    Joyce DA; Will RK; Hoffman DM; Laing B; Blackbourn SJ
    Ann Rheum Dis; 1991 Dec; 50(12):913-4. PubMed ID: 1768158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM; Vacek PM; Cooper SM
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis.
    Hanrahan PS; Russell AS
    J Rheumatol; 1988 Jul; 15(7):1078-80. PubMed ID: 3050087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients.
    Tishler M; Caspi D; Fishel B; Yaron M
    Arthritis Rheum; 1988 Jul; 31(7):906-8. PubMed ID: 3260783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial.
    Shiroky JB; Neville C; Esdaile JM; Choquette D; Zummer M; Hazeltine M; Bykerk V; Kanji M; St-Pierre A; Robidoux L
    Arthritis Rheum; 1993 Jun; 36(6):795-803. PubMed ID: 8507221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial.
    Weinblatt ME; Maier AL; Coblyn JS
    J Rheumatol; 1993 Jun; 20(6):950-2. PubMed ID: 8350329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of comedication with folic or folinic acid on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a randomized, double blind, placebo controlled study of 48 weeks].
    Jansen TL; Spoorenberg A; Houtman PM; van Roon EN
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2168; author reply 2168. PubMed ID: 12474559
    [No Abstract]   [Full Text] [Related]  

  • 9. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis.
    Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ
    J Rheumatol; 2004 May; 31(5):902-8. PubMed ID: 15124248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of folinic acid on low-dose methotrexate genotoxicity.
    Shahin AA; Ismail MM; Saleh AM; Moustafa HA; Aboul-Ella AA; Gabr HM
    Z Rheumatol; 2001 Apr; 60(2):63-8. PubMed ID: 11383050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.
    Ortiz Z; Shea B; Suarez-Almazor ME; Moher D; Wells GA; Tugwell P
    J Rheumatol; 1998 Jan; 25(1):36-43. PubMed ID: 9458200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
    Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
    Prey S; Paul C
    Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.
    Morgan SL; Baggott JE; Vaughn WH; Austin JS; Veitch TA; Lee JY; Koopman WJ; Krumdieck CL; Alarcón GS
    Ann Intern Med; 1994 Dec; 121(11):833-41. PubMed ID: 7978695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic and folinic acid supplementation reduces methotrexate gastrointestinal side effects in rheumatoid arthritis.
    Pincus T
    Clin Exp Rheumatol; 1998; 16(6):667-8. PubMed ID: 9844757
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
    Caporali R; Cimmino MA; Ferraccioli G; Gerli R; Klersy C; Salvarani C; Montecucco C;
    Ann Intern Med; 2004 Oct; 141(7):493-500. PubMed ID: 15466766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.